Tag: Alzheimers
Eli Lilly Alzheimer’s drug FDA approval delayed
Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.'s shares climbed in early US trading after its exp [...]
Biogen drops Alzheimer’s drug Aduhelm to focus on Leqembi, others
The Biogen headquarters in Cambridge, Massachusetts, on Tuesday, Oct. 24, 2023.Vanessa Leroy | Bloomberg | Getty ImagesBiogen on Wednesday said it wil [...]
Alzheimer’s drug Leqembi shows promise as injection
Eisai on Wednesday said an injectable version of the Alzheimer's drug Leqembi showed promising initial results in a clinical trial, potentially paving [...]
Alzheimer’s drug Leqembi sales may be slow at first: Analysts
Jay Reinstein, who suffers from Alzheimer's, receives an injection so he can have a PET scan at MedStar Georgetown University Hospital in Washington, [...]
FDA approves Alzheimer’s drug Leqembi from Eisai, Biogen
The Food and Drug Administration on Thursday approved the Alzheimer's treatment Leqembi, a pivotal decision that is expected to expand access to the e [...]
States urge Medicare to cover Alzheimer’s treatments
Democratic and Republican attorneys general in nearly half of U.S. states are calling on Medicare to provide unrestricted coverage of antibody treatme [...]
Biogen not worried about Alzheimer’s competition with Eli Lilly
A person skateboards past Biogen Inc. headquarters in Cambridge, Massachusetts, on Monday, June 7, 2021.Adam Glanzman | Bloomberg | Getty ImagesBiogen [...]
Lecanemab, a new Alzheimer’s drug, could soon get FDA approval. Does it actually work?
A new Alzheimer’s medication appears to be on the verge of approval by the US Food and Drug Administration. But such a major milestone, given the p [...]
Eli Lilly CEO on guidance cut, potential obesity drug, Alzheimer’s study
Eli Lilly (LLY) CEO David Ricks on Tuesday expressed optimism around the drugmaker's innovation pipeline Tuesday, a stance we share despite the Club h [...]
Covid may trigger important rise in dementia circumstances: Alzheimer’s group
Folks carrying masks wait to cross a highway within the Shibuya district on Feb. 2, 2020 in Tokyo, Japan.Tomohiro Ohsumi | Getty Photographs Inform [...]
Biogen’s controversial Alzheimer’s drug generates $2 million in first few weeks after approval
Aduhelm by BiogenSupply: BiogenBiogen's Alzheimer's drug, Adhulem, generated $2 million in income within the first few weeks of its approval, the c [...]
Alzheimer’s illness was already terrifying. Aduhelm may very well make it worse.
Alzheimer’s illness is, amongst all of the illnesses that afflict humanity, maybe probably the most terrifying: a illness that robs an individua [...]
How the brand new Alzheimer’s illness drug might affect future analysis
The FDA’s current approval of the Alzheimer’s drug aducanumab is an important crossroads within the persevering with seek for a remedy for this [...]
